99mTc-tricabonyl labeling of ofloxacin and its biological evaluation in Staphylococcus aureus as an infection imaging agent

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 56, Issue 12, 2013, Pages 627-631

  Erfani, Mostafa ^a   Doroudi, Alireza ^b   Hadisi, Leila ^b   Andishmand, Ali ^b   Mirshojaei, Seyedeh Fatemeh ^a   Shafiei, Mohammad ^a  

^a NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

infection; ofloxacin; Staphylococcus aureus

Indexed keywords

ALCOHOLS; BACTERIA; CHEMICAL STABILITY; MAMMALS;

BIODISTRIBUTIONS; IMAGING AGENT; INFECTION; LABELINGS; LIPOPHILICITY; OFLOXACIN; RADIOLIGANDS; SPECIFIC BINDING; STAPHYLOCOCCUS AUREUS; [CARBONYL;

MUSCLE;

OFLOXACIN; OFLOXACIN TC 99M TRICARBONYL; RADIOLIGAND; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SCREENING; DRUG STABILITY; DRUG UPTAKE; IN VITRO STUDY; ISOTOPE LABELING; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; PARTITION COEFFICIENT; RADIOACTIVITY; RADIOCHEMISTRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE; STAPHYLOCOCCUS AUREUS;

MUS; STAPHYLOCOCCUS AUREUS;

99MTC-CARBONYL; INFECTION; OFLOXACIN; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ISOTOPE LABELING; MALE; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; OFLOXACIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TECHNETIUM;

EID: 84887821473     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.3093     Document Type: Article

References (19)

1. A. M. Peters, Semin. Nucl. Med. 1994, 24 (2), 110-127.
2. V. N. Ardoso, P. J. Plaza, M. Roca, F. Armero, J. Martin-Comin, Nucl. Med. Commun. 2002, 23 (8), 715-720.
3. C. J. Palestro, Semin. Nucl. Med. 1994, 24 (2), 128-141.
4. M. Zasloff, Nature 2002, 415, 389-395.
5. M. M. Welling, P. H. Nibbering, A. Paulusma-Annema, P. S. Hiemstra, E. K. J. Pauwels, W. Calame, J. Nucl. Med. 1999, 40, 2073-2080.
6. M. Gandomkar, R. Najafi, M. Mazidi, S. H. Mirfallah, M. Goudarzi, Iran. J. Radiat. Res. 2009, 7 (2), 97-104.
7. M. Gandomkar, R. Najafi, M. Mazidi, M. Goudarzi, S. H. Mirfallah, Iran. J. Nucl. Med. 2008, 16 (1), 25-30.
8. M. Gandomkar, R. Najafi, M. Shafiei, M. Mazidi, M. Goudarzi, S. H. Mirfallah, F. Ebrahimi, H. R. Heydarpor, N. Abdie, Nucl. Med. Biol. 2009, 36 (2), 199-205.
9. B. Fournier, X. Zhao, T. Lu, K. Drlica, D. C. Hooper, Antimicrob. Agents Chemother. 2000, 44 (8), 2160-2165.
10. S. F. Mirshojaei, M. Erfani, S. E. S. Ebrahimi, M. H. Talebi, F. Haj Hassan Abbasi, Iran. J. Nucl. Med. 2010, 18 (2), 45-51.
11. K. E. Britton, S. Vinjamuri, A. V. Hall, K. Solanki, Q. H. Siraj, J. Bomanji, S. S. Das, Eur. J. Nucl. Med. 1997, 24 (5), 553-556.
12. S. F. Mirshojaei, M. Gandomkar, R. Najafi, S. E. S. Ebrahimi, M. H. Babaei, A. Shafiei, M. H. Talebi, J. Radioanal. Nucl. Chem. 2011, 287, 21-25.
13. S. Vinjamuri, A. V. Hall, K. K. Solanki, J. Bomanji, Q. Siraj, E. O'Shaughnessy, S. S. Das, K. E. Britton, Lancet 1996, 347, 233-235.
14. K. K. Solanki, J. Bomanji, Q. H. Siraj, M. Small, K. E. Britton, J. Nucl. Med. 1993, 34 (Suppl), 119P.
15. L. Sarda, A. C. Crémieux, Y. Lebellec, A. Meulemans, R. Lebtahi, G. Hayem, R. Genin, N. Delahaye, D. Huten, D. Le Guludec, J. Nucl. Med. 2003, 44 (6), 920-926.
16. A. K. Sing, A. Bhatnagar, T. Singh, T. L. Mathew, Indian patent filed, 2001 May.
17. N. Bhardwaj, A. Bhatnagar, A. K. Singh, World J. Nucl. Med. 2005, 4, 244-251.
18. M. A. Motaleb, J. Radioanal. Nucl. Chem. 2007, 272, 95-99.
19. R. Alberto, R. Schibli, A. Egli, A. P. Schubiger, J. Am. Chem. Soc. 1998, 120, 7987-7988.